Will ChrysCap beat benchmark returns again in second exit from Mankind Pharma?
Indian private equity firm ChrysCapital has lined up a partial exit from Mankind Pharma, four years after returning to back the drugmaker after a previous exit. The partial exit comes at a time when ChrysCapital, one of the biggest Indian PE firms, is on the road to seek capital commitments […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.
